Abbott (ABT)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ABBOTT LABORATORIES (ABT) CIK: 0000001800 --- Reporting Owner --- Name: Roman Michael F CIK: 0001577544 Role: Director --- Derivative Transactions --- [Transaction #1] Security: Stock Equivalent Units Date: 2026-06-30 | Code: A (Grant or award) Shares: +416 | Price: $90.74 Shares Owned After: 6,746 | Ownership: D (Direct) Footnotes: [F1] Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. [F1] Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. [F1] Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. [F2] Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. --- Footnotes (Complete Index) --- F1: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. --- Signature --- /s/ /s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact (2026-07-01)